GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » E10

Sci Pharmtech (TPE:4119) E10 : NT$3.82 (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Sci Pharmtech E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sci Pharmtech's adjusted earnings per share data for the three months ended in Dec. 2024 was NT$0.390. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$3.82 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Sci Pharmtech's average E10 Growth Rate was 6.10% per year. During the past 3 years, the average E10 Growth Rate was 5.20% per year. During the past 5 years, the average E10 Growth Rate was 4.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sci Pharmtech was 5.20% per year. The lowest was 4.40% per year. And the median was 4.60% per year.

As of today (2025-04-06), Sci Pharmtech's current stock price is NT$78.30. Sci Pharmtech's E10 for the quarter that ended in Dec. 2024 was NT$3.82. Sci Pharmtech's Shiller PE Ratio of today is 20.50.

During the past 13 years, the highest Shiller PE Ratio of Sci Pharmtech was 33.24. The lowest was 17.70. And the median was 24.20.


Sci Pharmtech E10 Historical Data

The historical data trend for Sci Pharmtech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sci Pharmtech E10 Chart

Sci Pharmtech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.15 3.28 3.45 3.60 3.82

Sci Pharmtech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.60 3.63 3.58 3.84 3.82

Competitive Comparison of Sci Pharmtech's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Sci Pharmtech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sci Pharmtech's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sci Pharmtech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sci Pharmtech's Shiller PE Ratio falls into.


;
;

Sci Pharmtech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sci Pharmtech's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.39/133.1571*133.1571
=0.390

Current CPI (Dec. 2024) = 133.1571.

Sci Pharmtech Quarterly Data

per share eps CPI Adj_EPS
201503 0.875 99.621 1.170
201506 1.159 100.684 1.533
201509 0.882 100.392 1.170
201512 0.569 99.792 0.759
201603 1.444 100.470 1.914
201606 1.203 101.688 1.575
201609 0.860 101.861 1.124
201612 0.299 101.863 0.391
201703 0.467 102.862 0.605
201706 0.365 103.349 0.470
201709 0.372 104.136 0.476
201712 0.540 104.011 0.691
201803 0.562 105.290 0.711
201806 1.364 106.317 1.708
201809 1.159 106.507 1.449
201812 0.992 105.998 1.246
201903 1.495 107.251 1.856
201906 1.437 108.070 1.771
201909 1.458 108.329 1.792
201912 0.817 108.420 1.003
202003 1.896 108.902 2.318
202006 2.210 108.767 2.706
202009 1.724 109.815 2.090
202012 -2.555 109.897 -3.096
202103 0.376 111.754 0.448
202106 0.035 114.631 0.041
202109 0.271 115.734 0.312
202112 -0.184 117.630 -0.208
202203 0.376 121.301 0.413
202206 1.146 125.017 1.221
202209 0.443 125.227 0.471
202212 0.763 125.222 0.811
202303 0.590 127.348 0.617
202306 1.860 128.729 1.924
202309 0.330 129.860 0.338
202312 -0.080 129.419 -0.082
202403 0.370 131.776 0.374
202406 0.520 132.554 0.522
202409 3.180 133.029 3.183
202412 0.390 133.157 0.390

Add all the adjusted EPS together and divide 10 will get our e10.


Sci Pharmtech  (TPE:4119) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sci Pharmtech's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=78.30/3.82
=20.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sci Pharmtech was 33.24. The lowest was 17.70. And the median was 24.20.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sci Pharmtech E10 Related Terms

Thank you for viewing the detailed overview of Sci Pharmtech's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Sci Pharmtech Business Description

Traded in Other Exchanges
N/A
Address
No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856
Sci Pharmtech Inc is engaged in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals. Geographically, the primary markets of the company are Italy, Germany, Japan, Taiwan, the United States, China, Switzerland, Spain, and others.

Sci Pharmtech Headlines

No Headlines